test 4 Flashcards
hydrocortisone
corticosteroid, short to medium acting
2+ mineralcorticoid activity
prednisone
corticosteroid, short to medium acting
1+ mineralcorticoid activity
use in treatment of allergic disorders, cerebral edema (vasogenic and abcess edema), Collagen disorders
methylprednisolone
corticosteroid, short to medium acting
use in treatment of allergic disorders,Collagen disorders
pediatric renal disease
triamcinolone
corticosteroid, intermediate acting
0 mineralcorticoid activity
use in treatment of allergic disorders, Collagen disorders
SE: myopathy
ketoconazole
glucocorticoid synthesis inhibitor and antagonist
anti fungal
inhibits 17a Hydroxylase and stops all steroid biosynthesis, best treatment for bushings disease
fludrocortisone
mineralcorticoid agonist( most widely used) both mineral and glucocorticoid activity used in adrenocortical insufficiency with mineral corticoid deficiency
spironolactone
glucocorticoid and mineralocorticoid antagonist
used to normalize K concentration sin HYPER aldosteronis
Cosyntropin
Glucocorticoid, mineralocorticoid, androgen, progesterone and estrogen agonist
dexamehazone
long acting corticosteroid
0 mineralcorticoid activity
use in treatment of allergic disorders, acute nonTB bacterial meningitis
stopping TNFa and IL-1B and cytokines production, Collagen disorders
metyrapoine
glucocorticoid synthesis inhibitor and antagonist
inhibits 11 B hydroxylase in cushings patients
zona glomerulosa secretes
mineralocorticoids, aldosterone
zona fasciculata secretes
glucocorticoids, cortisol
zona reticularis
androgens, progesterone, estrogens
Aspirin
anti platelet
irreversibly acetylates COX
inhibiting TXA2 synthesis
low dose (1-2mg/kg) preserves PGI2 production with still inhibiting TXA2
USE: prevent MI, ischemic attack,ischemic stroke, arterial thrombotic event, prevent vein graft occlusion
Adverse RXN: adbominal discomfort, GI bleed, ab discomfort, inpaired surgical hemostasis, risks in pregnancy
dipyridamole
anti platelet
inhibits Phosphodiesterase thus increasing [cAMP]
increased [cAMP] (via adenylate cyclase) blocks TXA2 production
clopidiigrel
anti platelet, inhibits platelet aggregation
inhibits ADP binding to P2Y12 componenet of ADP receptor
preventing activation of GPIIb/IIIa
works for life of the platelet
tirofiban
anti platelet
reversible antagonist of fibrinogen binging to the GPIIb/IIIa receptor
a non peptide antagonist
heparin
anti coagulant
MOA: binds to lysine on AT-III accelerating inactivation of Thrombin and factor Xa, also interacts with platelets to inhibit function/ induce aggregation causing thrombocytopenia
use: when rapid effects are needed, pregnancy instead of other teratogens ( oral anticoag like warfarin)
antidote :protamine sulfate
interact; SUPRESSES aldosterone, interacts with insulin
enoxaparin Na
anti coagulant
protamine sulfate
anti coagulant
rich in arginine and strongly basic
bind and inactivates Heparin( instantaneous effect for 2 hours), careful monitoring b/c it has anti coat effect by itself
SE: transient HypoTN, anaphylaxis in fish allergies, less effective against LMW HEPARIN
warfarin Na
anti coagulant
blocks vitamin K required for post translation modification of essential clot factors
Vitamin K epoxide reductase inhibition, inhibiting gamma corboxylationof N-terminal Glu acid
DONT USE in PREG- crosses placenta and teratogenic
reversal is Fresh frozen plasma and VIT K1
SE: hemorrhage and HTN
Lepirudin
anti coagulant, naturally occurring in leeches,
directly inhibits thrombin, 1:1 binding
use: heparin puts with thrombocytopenia
Adverse RXN: hyper sensativity, bleeding, crosses placenta in rats only use in pre if absolute needed, NO ANTIDOTE available
alteplase
thrombolytic, recombinant form of tPA
activates fibrin bound plasminogen to plasmin
reversal with aminocaprotic acid
aminocaprotic acid
fibrinolysis inhibitor
selectively inhibits plasminogen activation
factor VIII
defecit is Hemophilia a
x linked recessive
Factor IX
defecit is hemophilia b
x linked recessive
Phytonadione
vitamin K1
anticoagulants
interfere with fibrin formation, and used to prevent thrombus formation
major use in venus thromboembolic disorders b/c of stasis and not vessel damage
bleeding is main complication of therapy
- adverse rxn to Heparin
- inactivation
bleeding
thrombocytopenia
hypersensativity
local capillary rupture in SC and IM dose
suppression of Aldosterone
REVERSAL: protamine sulfate IV administration
Urokinase
directly activates plasminogen by proteolytic cleavage to produce plasmin
non antigenic